The Continental landscape presents a fascinating evolution in the understanding of psychedelics. Recently stigmatized, these substances are now gain traction for their medical applications. From the Netherlands, where studies are in progress, to the UK, where awareness is growing, Europe is at the forefront in this resurgence of copyright culture.